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Cosxkun et al. now map fetal bone marrow
niche development and examine the
impact of its cellular components on
HSC phenotype and function.
Cell Reports
ArticleDevelopment of the Fetal Bone Marrow Niche
and Regulation of HSC Quiescence and Homing
Ability by Emerging Osteolineage Cells
Su¨leyman Cosxkun,1,2 Hsu Chao,2 Hema Vasavada,1 Kartoosh Heydari,3 Naomi Gonzales,2 Xin Zhou,4
Benoit de Crombrugghe,4 and Karen K. Hirschi1,2,*
1Yale Cardiovascular Research Center, Department of Internal Medicine, Vascular Biology and Therapeutics Program and Yale Stem Cell
Center, Yale University School of Medicine, 300 George Street, New Haven, CT 06511, USA
2Children’s Nutrition Research Center and Center for Cell and Gene Therapy, Departments of Pediatrics and Molecular and Cellular Biology,
Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
3Cell Sorter Core Facility, Yale University School of Medicine, 330 Cedar Street, New Haven, CT 06511, USA
4Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
*Correspondence: karen.hirschi@yale.edu
http://dx.doi.org/10.1016/j.celrep.2014.09.013
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARY
Hematopoietic stem cells (HSCs) reside within a
specialized niche where interactions with vascula-
ture, osteoblasts, and stromal components regulate
their self-renewal and differentiation. Little is known
about bone marrow niche formation or the role of
its cellular components in HSC development; there-
fore, we established the timing of murine fetal long
bone vascularization and ossification relative to the
onset of HSC activity. Adult-repopulating HSCs
emerged at embryonic day 16.5 (E16.5), coincident
with marrow vascularization, and were contained
within the c-Kit+Sca-1+Lin (KSL) population. We
used Osterix-null (Osx/) mice that form vascular-
ized marrow but lack osteolineage cells to dissect
the role(s) of these cellular components in HSC
development.Osx/ fetal bonemarrow cells formed
multilineage colonies in vitro but were hyperprolifer-
ative and failed to home to and/or engraft transplant
recipients. Thus, in developing bone marrow, the
vasculature can sustain multilineage progenitors,
but interactions with osteolineage cells are needed
to regulate long-termHSCproliferation and potential.
INTRODUCTION
Hematopoietic stem cells (HSCs) provide a lifelong blood supply,
and this critical function relies on balanced regulation of self-
renewal and differentiation provided within a specialized micro-
environment (niche). Bonemarrow serves as themain HSC niche
in vertebrates after birth; however, during embryogenesis, HSCs
emerge and/or migrate through different tissues (reviewed in
Coskun and Hirschi, 2010). In mice, multilineage hematopoietic
progenitors first arise within the extraembryonic yolk sac at
approximately embryonic day 8.25 (E8.25) (Palis et al., 1999).CThe placenta and embryonic aorta-gonad-mesonephros (AGM)
region exhibit de novo HSC potential at E10 (Gekas et al.,
2005; Medvinsky and Dzierzak, 1996; Ottersbach and Dzierzak,
2005), and at E11.0, HSCs reside within fetal liver (Morrison et al.,
1995). Finally, HSCs home to and/or emerge within fetal bone
marrow shortly before birth, where they reside postnatally.
One common feature of all hematopoietic sites is that multili-
neage hematopoietic stem/progenitor cells are closely associ-
ated with blood vessels; in fact, they arise from specialized
(hemogenic) vascular endothelial cells in the yolk sac, AGM,
and placenta (reviewed in Hirschi, 2012). Even in adult bone
marrow, HSCs are closely associated with sinusoidal endothelial
cells and perivascular cells in the trabecular regions of long
bones (Ding et al., 2012; Kiel et al., 2005; Nombela-Arrieta
et al., 2013), which regulate HSC survival and proliferation
(Garrett and Emerson, 2009). Furthermore, mesenchymal cells
around arterioles have been shown to regulate HSC quiescence
(Kunisaki et al., 2013). HSCs within adult bone marrow are also
closely associated with osteoblasts (Calvi et al., 2003; Zhang
et al., 2003), which are unique to the bone marrowmicroenviron-
ment. The extent to which the vasculature and osteoblasts are
developedwithin fetal bone at the onset of HSC activity, and their
relative contribution to the regulation of HSC phenotype, prolifer-
ation, and function, are investigated herein.
We first established the time course of vascularization and
ossification of murine fetal long bones (femur), relative to the
onset of HSC activity, and assessed the phenotype of fetal
bone marrow HSCs. We found that adult repopulating HSCs
were first present at E16.5, coincident with vascular perfusion,
and were contained within the c-Kit+Sca-1+Lin (KSL) popula-
tion. Collagen type I, alpha 1 (Col1a1)-expressing mature osteo-
blasts were also present within fetal bone at E16.5, although
predominantly localized within the periosteum. To discern the
roles of vasculature versus osteolineage cells in the regulation
of fetal bone marrow HSC function, we used Osx/ mutants
that form vascularized marrow but lack osteoblasts and osteoli-
neage cells. Fetal bone marrow cells from Osx/ mutants
formed multilineage hematopoietic colonies in vitro. However,ell Reports 9, 581–590, October 23, 2014 ª2014 The Authors 581
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Figure 1. Fetal Bone Is Vascularized within
the Middle Region at E16.5 when Hemato-
poietic Stem/Progenitor Cell Activity Is
Initially Detected
(A) Mouse E15.5–E17.5 fetuses were injected with
100 ml Dextran-FITC (70 kDa) via the superficial
temporal vein to reveal functional blood vessels.
Fetal femurswere avascular at E15.5, but perfused
by E16.5, specifically in the middle regions. Lon-
gitudinal bone cross-section, green: Dextran-
FITC, blue: nuclear DAPI. Scale bar, 100 mm.
(B) Composition of fetal bone was revealed via
alizarin red (mineralized tissue) and alcian blue
(cartilage) staining. Calcification was apparent
by E16.5 in the middle regions and present
throughout the tissue by E17.5.
(C) At E16.5, Col1a1-positive mature osteoblasts
were detected at the periosteum and throughout
the bone at E17.5. Longitudinal bone cross-sec-
tion; scale bar, 100 mm.
(D) HSPC activity was first detected at E16.5 in
the middle regions of bone. Multilineage colonies
containinggranulocyte, erythrocyte,monocyte, and
megakaryocyte (CFU-GEMM) were scored from
20,000 cells/well for each embryonic time point by
Methocult assay.Data representmean±SEM(n=3).KSL cells isolated from Osx/ fetal bone marrow exhibited hy-
perproliferation and dysregulation of cell-cycle genes and failed
to engraft transplant recipients. In contrast, fetal liver cells from
Osx/ mutants exhibited higher engraftment than wild-type lit-
termates. In addition, total blood cell counts in Osx/ mutants
were normal, suggesting that Osx/ mutants do not exhibit a
defect in definitive hematopoiesis, per se, but rather a defective
fetal bone marrow microenvironment that cannot support the
development or maintenance of long-term (LT) HSCs. Further
elucidating the molecular role of cellular niche components in
HSC development should provide insights needed to modulate
adult hematopoiesis and enable recapitulation of a niche micro-
environment ex vivo to sustain HSC for clinical therapies.
RESULTS
Time Course of Fetal Bone Marrow Niche Development
To define the formation of the fetal bone marrow niche and begin
to dissect the effects of its cellular components on HSC pheno-
type and function, we first established the time course of vascu-
larization of developing femurs of C57BL/6J mice at E15.5
through E17.5 via intravenous Dextran-fluorescein isothiocya-
nate (FITC) injection (Kienstra et al., 2007). We found that the car-
tilagenous bone templates were avascular at E15.5 (Figure 1A)
and exhibited perfusion in the periosteum region and epiphyseal
plate at E16 (Figure S1A). Themiddle, marrow region of fetal long582 Cell Reports 9, 581–590, October 23, 2014 ª2014 The Authorsbone was not perfused until E16.5
(Figure 1A). The functional vasculature
then extended bidirectionally away from
the marrow center, and at E17.5, most of
the bonemarrowcavitywas vascularized.
To establish the time course of calcifi-
cation/osteogenesis of developing long
bones, relative to vascular perfusion, we used alcian blue and
alizarin red stains to distinguish cartilage and calcified bone,
respectively (Inouye, 1976). At E15.5 and E16, fetal femurs
were composed only of cartilage (Figures 1B and S1B, respec-
tively; light blue staining). Calcification was apparent by E16.5
in the middle regions (Figure 1B, dark red staining), and present
throughout the tissue by E17.5. Thus, the pattern of calcification
over time paralleled that of the forming vascular network. We
next evaluated the presence of osteoblasts within the femurs
and localized them relative to the developing endothelium
via coimmunofluorescence using antibodies against collagen
type I, alpha 1 (Col1a1, osteoblasts) and CD31 (endothelial cells).
Osteoblasts were not present at E15.5 (not shown), but they
localized to the periosteum at E16.5 (Figure 1C) and throughout
the bone marrow cavity and periosteum at E17.5 (Figure 1C).
HSC Activity Localizes to Vascularized Regions of
Fetal Bone
We next defined the temporal and spatial emergence of HSC
activity within fetal long bones. Femurs from E15.5–E17.5
fetuses were dissected into three anatomical regions: proximal
(P), middle (M), and distal (D) (Figure 1D, insert). Single-cell sus-
pensions obtained from each tissue were subjected to an in vitro
hematopoietic (Methocult) assay in which the formation of
colonies containing multiple blood cell lineages including
granulocytes, erythrocytes, monocytes, and megakaryocytes
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Figure 2. Fetal Bone Marrow Hemato-
poietic Activity Is Restricted to the KSL
Population, which Is More Actively Prolifer-
ating Than Adult Bone Marrow KSL and
Gives Rise to All Blood Lineages
(A) 100 KSL and 1000 non-KSL cells from fetal
bone marrow were sorted and cultured in
Methocult; only KSL cells exhibited multilineage
colony-forming activity. Data represent mean ±
SEM (n = 3); p = 0.007 (E16.5), p = 0.0005 (E17.5),
and p = 0.00001 (E18.5).
(B) Cell-cycle distribution of the fetal and adult
bonemarrowKSLcellswas revealedusingPyronin
Y/Hoechst dyes and flow cytometry. KSL cells
weremoreactivelyproliferating in fetal versusadult
bonemarrow. Data represent mean ± SEM (n = 3).
(C) Engraftment levels were determined at 4, 12,
and 20 weeks posttransplantation by analyzing
peripheral blood CD45.2 (donor) and CD45.1
(recipient) levels. LT-HSCs were first present at
E16.5 and showed engraftment levels up to 35%
at 20 weeks posttransplant. By E17.5, engraft-
ment level was comparable to adult bone marrow
HSCs. Data represent mean ± SEM (n = 3). Dif-
ferences between E16.5 and either E17.5 or adult
were significant; p = 0.00085 (week 4), p =
0.00326 (week 12), and p = 0.00503 (week 20).
(D) Lineage analysis revealed fetal bone marrow
cells (E16.5–E17.5) gave rise to all blood lineages
in vivo. Data represent mean ± SEM (n = 3).(CFU-GEMM) indicates the presence of multilineage hematopoi-
etic stem/progenitor cells (HSPCs). The first fetal bone marrow
HSPC activity was detected at E16.5 (Figure 1D), and it was
restricted to the vascularized (middle) region of the developing
bones (Figure 1A). At E17.5, CFU-GEMMcolony-forming HSPCs
were detected throughout the bone tissue (Figure 1D). Thus, un-
like adult HSCs that reside mainly within trabecular (proximal/
distal) regions of bone, fetal bone HSPCs are localized to the
central (middle), vascularized marrow.
Defining the Phenotype of Fetal Bone Marrow HSCs
To define the phenotype of HSPCs in fetal bone marrow, we
used methods previously applied to adult mouse bone marrow:
Hoechst dye exclusion to identify side population (SP) cells
(Goodell et al., 1996) and isolation based on expression of
c-Kit and Sca-1 and absence of blood lineage markers (KSL
population) (Morrison and Weissman, 1994). Mac-1 antibodies
were excluded from the lineage cocktail since fetal HSPC ex-
pressMac-1 (Morrison et al., 1995). Unlike in adult bonemarrow,
SP cells were not detectable within fetal bone marrow at E16.5
and E17.5 but were present at E18.5 onward when evaluating
the same number of whole bone marrow (WBM) cells at each
time point (Figure S2A). In contrast, KSL cells were present within
fetal bone marrow beginning at E16.5, which we found to be the
onset of HSPC activity (Figures S2B and S2C). Furthermore,Cell Reports 9, 581–590,CFU-GEMM colony-forming activity
was restricted to KSL cells at all stages
of bonemarrowdevelopment (Figure 2A).
Consistent with this, cells coexpressingc-Kit and Sca-1 were localized to the central region of fetal
bone marrow that is highly enriched for HSPC activity (Fig-
ure S2D). We further evaluated the phenotype of fetal bone
marrow KSL cells at E17.5 and found that 19.63% ± 1.01% of
KSL cells wereCD150+CD48, which is thought to be the pheno-
type of LT-HSCs within adult bone marrow (Yilmaz et al., 2006).
Fetal Bone Marrow KSL Cells Are Highly Proliferative
Although HSCs within adult bone marrow are largely quiescent,
HSCs within fetal liver are more actively proliferating (Bowie
et al., 2006). To compare the proliferative status of fetal and adult
bone marrow HSCs, we isolated KSL cells from fetal and adult
femurs, stained them with Hoechst and Pyronin Y to label DNA
and RNA, respectively (Shapiro, 1981), and used flow cytometry
to quantify the proportion in each cell-cycle phase based on rela-
tive DNA and RNA content. We found that 35% of fetal bone
marrow KSL cells were in S/G2/M phase versus 13% of adult
KSL cells (Figure 2B). In contrast, 20% adult KSL cells were
in G0, relative to 10% fetal KSL cells, indicating KSL cells are
more actively proliferating in fetal versus adult bone marrow.
Adult Repopulating HSCs are Present within Fetal Bone
Marrow at E16.5
Although we detected multilineage hematopoietic potential in
E16.5 fetal bone marrow cells in vitro, we performed boneOctober 23, 2014 ª2014 The Authors 583
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Figure 3. Osx/ Fetal Bone Marrow Cells
Form Multilineage CFU-GEMM Colonies
In Vitro but Fail to Repopulate Transplanted
Recipients
(A) Osx/ fetal long bones lack osteoblasts and
have structural defects compared to wild-type
(WT); however, they have a normally vascularized
marrow, as revealed by isolectin B4-FITC staining.
Scale bar, 20 mm.
(B) Representative images of CFU-GEMM and
CFU-GM colonies formed from E16.5 and E17.5
Osx/ fetal bone marrow cells, similar to E17.5
WT fetal bone marrow cells.
(C) A total of 400,000 WT andOsx/WBM cells at
E17.5 were transplanted into sublethally irradiated
neonates, and engraftment levels were deter-
mined by analyzing recipients’ peripheral blood up
to 20 weeks posttransplant; E17.5 Osx/ WBM
cells did not engraft. Data represent mean ± SEM
(n = 3); p = 0.0003 (week 4), p = 0.016 (week 12),
and p = 0.03 (week 20).
(D) WT and Osx/-derived E17.5 fetal liver cells
repopulated transplant recipients’ peripheral
blood in vivo. Data represent mean ± SEM (n = 3);
p = 0.013 (week 4), p = 0.002 (week12) and p =
0.004 (week 20).marrow transplantation studies to assess engraftment and blood
cell generation in vivo to confirm the onset of LT-HSC activity.
Isolation of fetal bone marrow cells, pooled from multiple litters,
typically yields a fewmillion cells, of which we expect only 0.01%
to be LT-HSCs (Challen et al., 2009). Thus, we used unfractio-
nated WBM for these time course studies, which were isolated
from E15.5-17.5 fetal hindlimbs of CD45.2 donors and trans-
planted into lethally irradiated adult CD45.1 recipients (1 3 106
donor WBM cells + 2 3 105 CD45.1 adult WBM helper cells/
recipient; n = 3 per group). In vivo engraftment was first detected
at E16.5, with levels of 14.1%, 30.8%, and 32.8% at 4, 12, and
20 weeks posttransplantation, respectively (Figures 2C and
S3). Our data showed HSPC activity present within fetal bone
marrow at E16.5, which is a day earlier than previously described
(Christensen et al., 2004) and consistent with our in vitro colony-
forming assays. Lineage distribution analysis of the engrafted
cells confirmed that E16.5 fetal bone marrow contains LT-
HSCs that give rise to all blood lineages in adult recipients
(Figures 2D and S4). By E17.5, fetal WBM engraftment was com-
parable to adult bone marrow HSCs.
Fetal Bone Marrow Fails to Support LT-HSC Function in
the Absence of Osteoblasts
To discern the roles of the vasculature and osteolineage cells in
supporting LT-HSCs within fetal bone marrow, we used C57BL/
6J Osx/mice that lack osteoblasts and osteolineage cells and
die perinatally (Nakashima et al., 2002).Osx/ fetuses exhibited584 Cell Reports 9, 581–590, October 23, 2014 ª2014 The Authorsabnormal skeletal development (Fig-
ure 3A, E17.5 hindlimbs shown) but had
marrow that was vascularized similarly
to wild-type littermates (Figure 3A).
Osx/ fetal marrow also contained an
equal proportion of KSL cells (Figure S5A), which exhibited
similar apoptosis levels (Figure S5B), compared to wild-type
littermates.
We initially tested the hematopoietic function of E16.5 and
E17.5 Osx/ fetal marrow cells in vitro and found that they
formed multilineage CFU-GEMM colonies similar to wild-type
(Figure 3B). To test their LT-HSC activity in vivo, we first defined
theminimumnumber of fetal bonemarrow cells required to repo-
pulate recipients at a reproducible engraftment level. We iso-
lated E17.5 wild-type (C57BL/6J) WBM cells and transplanted
them into sublethally irradiated neonates (50,000–500,000
CD45.2 donor fetal cells + 200,000 CD45.1 adult WBM helper
cells /recipient; n = 4 per group). We used neonatal recipients
in these studies because we could achieve more consistent
engraftment with smaller numbers of donor cells, relative to adult
recipients.We found that 100,000 E17.5WTWBMcells/recipient
yielded 5%–10% engraftment at 4 weeks posttransplantation
(Figure S6A). We were able to isolate and transplant 400,000
WBM cells from each E17.5 Osx/ fetus; thus, expecting
>5%–10% engraftment; however, Osx/ WBM cells failed to
repopulate recipients even 20 weeks posttransplantation (Fig-
ure 3C). In contrast, Osx/-derived E17.5 fetal liver cells
exhibited significantly higher engraftment levels than wild-type
fetal liver cells (Figure 3D). In addition, we did not observe differ-
ences in total blood cell counts E17.5Osx/mutants compared
to wild-type littermates (Figures S6B and S6C). Thus, although
Osx/ mutants did not exhibit a global defect in definitive
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Figure 4. Fetal Bone Marrow Cells Derived
fromOsx/Mutants Exhibit a Homing Defect
(A) P0–P2 recipient neonates were euthanized 24 hr
posttransplantation, and bone marrow and liver
cells were analyzed with flow cytometry for donor/
recipient cell ratios.
(B) Fetal liver cells from E17.5 WT and Osx/ mu-
tants exhibited similar homing to liver and bone
marrow of WT recipients.
(C) In contrast, fetal WBM cells derived from E17.5
Osx/ mutants showed significantly reduced
homing compared to WT. Data represent mean ±
SEM (n = 3).hematopoiesis and Osx/ fetal bone marrow cells exhibited
HSPC activity in vitro, they failed to home to, or engraft within,
transplant recipients.
Fetal Bone Marrow Cells Derived from Osx/ Mutants
Exhibit a Homing Defect
To evaluate theHSChoming ability ofOsx/ versuswild-type lit-
termates, we isolated E17.5 fetal WBM and fetal liver cells from
each group of embryos. As depicted in Figure 4A, 400,000 cells
of each type (either WBM or liver cells from CD45.2 donor em-
bryos) were then injected into P0–P2 CD45.1 neonatal recipients
via the superficial temporal vein. Recipients were euthanized
after 24 hr, and bonemarrow and liver cells were collected imme-
diately. All cells were incubated with CD45.1-FITC (recipient) and
CD45.2-APC (donor) antibodies and analyzed by flow cytometry
to measure the ratio of donor:recipient cells in bone marrow and
liver. Cells derived fromOsx/ fetal liver showed normal homing
to recipient liver and bone marrow (Figure 4B); however, Osx/
fetal bone marrow cells exhibited significantly reduced homing
ability (Figure 4C). Thus, osteoblasts or osteolineage cells appear
to be required within fetal bone marrow to establish or maintain
the homing ability of LT-HSCs.
Dysregulation of the Fetal Bone Marrow Niche and
HSPCs in Osterix-Null Mutants
To investigate the impact of osteoblast and osteolineage cell
deficiency on the fetal bone marrow microenvironment, we iso-Cell Reports 9, 581–590lated total RNA from E17.5 Osx/,
Osx+/, and wild-type WBM cells and
compared their relative expression of
niche-regulatory and cell-type-specific
genes (Table S1). As expected, Osx gene
expression was 40% lower in Osx+/
WBM and absent in Osx/ WBM (Fig-
ure 5A), thus validating our quantitative
PCR (qPCR) analysis. Osx/ WBM also
exhibited significantly decreased expres-
sion of osteoblast-derived osteopontin
(opn) and N-cadherin (cdh2) (Figure 5B).
In contrast, expression of endothelial-
associated genes VE-cadherin (cdh5),
vascular endothelial growth factor receptor
2 (vegfr2), and integrin subunits a5 (itga5)
and b1 (itgb1) were significantly increasedinOsx/WBM (Figure 5B). Nestin, which is expressed by prolif-
erating endothelial cells (Suzuki et al., 2010), and vascular-
derived Cxcl12 (SDF-1) and Kit ligand (KitL or SCF), which
regulate HSC migration and homing (Christensen et al., 2004),
were also significantly increased in Osx/ WBM, suggesting
increased representation of vascular cells in osterix-null fetal
bone marrow, which is consistent with flow cytometric analysis
of the cellular composition of Osx/ fetal bone marrow, relative
to wild-type littermates (Figure S6D).
To determine the effects of osterix deficiency on the pheno-
type of HSPCs specifically, we sorted fetal bone marrow KSL
cells from the hindlimbs and forelimbs of E17.5 Osx/ and
wild-type littermates and pooled them into ten-cell samples,
the minimum number that could be reproducibly analyzed. Total
RNA was isolated and analyzed via qPCR. We found that KSL
cells isolated from Osx/ fetal bone marrow exhibited a trend
toward downregulation of b1 integrin (itgb1, Figure 5C), which
plays a significant role in HSC retention in hematopoietic tissues
(Potocnik et al., 2000). The hypoxia-activated gene Hif1a and
one of its downstream targets, VEGF-A, which is known to regu-
late HSC survival in adult bone marrow (Takubo et al., 2010),
were also reduced in KSL cells isolated from Osx/ fetal bone
marrow (Figure 5C). In contrast, we found a trend toward upregu-
lation of genes known to regulate HSC proliferation, including
p21, p53, and CD38, in Osx/ mutants (Figure 5D). These
expression data are consistent with the observed hyperprolifer-
ative phenotype of KSL cells isolated from Osx/ fetal bone, October 23, 2014 ª2014 The Authors 585
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Figure 5. Gene Expression Studies Re-
vealed that Genes Specific to the Bone
Marrow Niche and HSPCs Are Dysregulated
in Osterix Mutants
(A) Gene expression analysis (via qPCR) was per-
formed on E17.5 WT and Osx/ WBM cells. Osx
expression was 40% decreased in Osx+/
fetuses and absent in Osx/ mutants.
(B) N-cadherin (cdh2) and osteopontin (opn) were
significantly downregulated in Osx/ mutants,
whereas Cxcl12, kitL (SCF), nestin, vascular-
endothelial cell adhesion protein, VE-cadherin
(cdh5), vascular-endothelial growth factor recep-
tor 2 (vegfr2), and integrin subunits b1 (itgb1) and
a5 (itga5) were significantly upregulated compared
toWT (*p% 0.01, **p% 0.001, and ***p% 0.0001).
b-actin gene expression was used as an internal
control. For each gene of interest, triplicates from
four different cDNA samples were analyzed. Data
represent mean ± SEM (n = 4; triplicates for each
sample).
(C and D) KSL cells were isolated from the hin-
dlimbs of E17.5 WT and Osx/ mutants and
analyzed in ten-cell pools. In Osx/ KSL cells, the
expression of CD38, p21, p53, as well as Tie2 and
CD44, trended toward higher than wild-type lit-
termates, whereas expression of Hif1a and VegfA
trended toward lower. b-Actin served as an inter-
nal control. Statistical analyses were done using
the two-tailed unpaired Student’s t test. Data
represent mean ± SEM (n = 4); p = 0.30 (CD38), p =
0.15 (p21), p = 0.30 (p53), p = 0.17 (Tie-2), p = 0.28
(CD44), p = 0.44 (Hif1a), p = 0.33 (Vegfa), p = 0.5
(itgb1), p = 0.79 (Selpg), p = 0.42 (itga4), and p =
0.29 (notch1).marrow that exhibited 30% less cells in G0 phase and 2.2-fold
more cells in S/G2/M phase, compared to wild-type littermates
(Figure S5C). Collectively, our data suggest that changes in
cellular composition and gene expression within the fetal bone
marrow microenvironment in Osterix-null mutants leads to
impaired ability to sustain LT-HSCs (as depicted in Figure 6).
DISCUSSION
The adult HSC niche has been extensively studied, and specific
cellular components, including osteoblasts (Calvi et al., 2003;
Zhang et al., 2003), vascular/perivascular cells (Ding et al.,
2012; Kiel et al., 2005; Kunisaki et al., 2013; Me´ndez-Ferrer
et al., 2010; Sugiyama et al., 2006), nestin-expressing mesen-
chymal stem cells (MSCs) (Me´ndez-Ferrer et al., 2010), adipo-
cytes (DiMascio et al., 2007), and neurons of the sympathetic
nervous system (Katayama et al., 2006), have been identified as
important regulatorsofHSCmaintenanceand function.However,
the formation of the bonemarrow niche during fetal development586 Cell Reports 9, 581–590, October 23, 2014 ª2014 The Authorshas not been studied, and the impact of
specific niche components on fetal bone
marrow HSC phenotype, proliferation,
and function has not been defined.
We investigated these issueshereinand
found that fetal long boneswere vascular-ized, and LT-HSCs emerged, coincidentally at E16.5. Further-
more, fetal bone marrow HSCs were contained within the KSL
population and localized specifically to the vascularized regions
of fetal long bones. HSCs within adult bone marrow are also
closely associated with vascular endothelial cells (Kiel et al.,
2005; Nombela-Arrieta et al., 2013), and the sinusoidal vascular
niche is thought to support active proliferation of HSCs (Winkler
et al., 2012). This is consistent with our observations in fetal
bone marrow, wherein vascular-associated HSCs were more
proliferative than adult HSCs. The subset of adult HSCs that
are more quiescent are thought to be associated with osteo-
blasts (Wilson et al., 2007), although the osteoblastic and
vascular niches may not be entirely separate entities (Ellis et al.,
2009). We found osteoblasts present within fetal bone at the
onset of HSC activity (E16.5); thus, we aimed to dissect the
differential roles of vascular and osteolineage niche components
on HSC development using osterix-null mice that exhibit normal
marrow vascularization but lack osteoblasts and osteolineage
cells.
Figure 6. Working Model
In wild-type (WT) fetal long bones (femur), adult re-
populating HSCs are first present at E16.5, coincident
with vascular perfusion, localized to vascularized re-
gions of bone, and highly proliferative relative to adult
HSCs. Osteoblast progenitors are also present within
fetal bone at this stage but appear to be restricted to
the periosteum. From E17.5 onward, HSCs are also
detected within the proximal and distal ends of bone
that are fully vascularized and contain mature osteo-
blasts that are thought to regulate HSC quiescence. In
Osx/ fetal bone marrow, osteoblasts and osteoline-
age cells do not develop, and there is increased
expression of vascular niche associated genes,
including VE-cadherin, Vegfr2, KitL, and cxcl12, as well
as decreased expression of N-cadherin and osteo-
pontin, which suggests increased representation of
vascular endothelial cells in this microenvironment in
osterix-null mutants. HSPC phenotype and function
are also altered in the osteolineage cell-deficient
microenvironment. Although KSL cells are present in
equal numbers compared to WT, and exhibit similar
apoptosis levels, KSL cells isolated from Osx/ fetal
bone marrow exhibited dysregulated cell-cycle pro-
gression and defective homing ability. These data
suggest that osteolineage cells in fetal bone marrow
play a critical role in establishing and sustaining LT-
HSC phenotype and function during development.We observed that fetal bone marrow cells from Osx/ mu-
tants exhibited multilineage colony-forming activity in vitro but
were hyperproliferative relative to wild-type littermates and
failed to repopulate transplant recipients. In contrast, fetal liver
cells isolated from Osx/ mutants successfully repopulated re-
cipients, and blood cell counts were similar betweenOsx/ and
wild-type littermates, demonstrating that there is not a global
defect in HSC and definitive hematopoiesis in Osx/ mutants
but rather a specific defect(s) in the bone marrow microenviron-
ment that fails to support the generation and/or maintenance of
LT-HSCs. These results are consistent with previous studies of
ectopic bone formation that suggest osteoblasts/progenitors
are necessary, but not sufficient, for HSC niche formation
(Chan et al., 2009).
To gain better understanding of the impact of osterix defi-
ciency on the bone marrow microenvironment, we performed
expression analysis of Osx/ and wild-type fetal WBM cells.
We found that the Osx/ mutants exhibited significantly
decreased N-cadherin (cdh2) and increased vascular-endothe-
lial (VE)-cadherin (cdh5) expression. Increased association of
HSCs with endothelial cells via VE-cadherin, and concomitant
lack of interaction with osteoblasts would be consistent with
the increased HSPC proliferation that we observed in theOsx/
mutants, given that N-cadherin knockdown in HSCs acceleratesCell Reports 9, 581–5their division and reduces their engraftment
(Hosokawa et al., 2010) (depicted in Figure 6).
We also compared the gene expression of
KSL cells, specifically, fromOsx/ and wild-
type littermates.Osx/KSL cells exhibited a
trend toward upregulation of Tie2, CD38, and
CD44 genes, all of which facilitate HSC adhe-sion/maintenance within their niche, and regulate their function
(Arai et al., 2004; Higuchi et al., 2003; Williams et al., 2013). For
example, CD38lo/HSCs engraft better than CD38+ HSCs (Higu-
chi et al., 2003); thus, higher levels of CD38 in Osx/ HSPCs
may contribute to their lack of engraftment. p21 and p53 levels
were also somewhat higher in KSL cells isolated from Osx/
fetal bone marrow, which may contribute to their disrupted cell
cycle and lack of stem cell function. In fact, constitutive expres-
sion of p53 results in exhaustion of the adult HSC pool and pre-
mature aging (Tyner et al., 2002).
Collectively, our data demonstrate that osterix deficiency
significantly disrupts development of the fetal bone marrow
microenvironment. Osterix-Cre-labeled cells have been shown
to give rise to osteoblasts and other stromal components in adult
bone marrow (Chen et al., 2014; Liu et al., 2013). Other osterix-
lineage tracing studies revealed that although osterix-expressing
cells predominantly give rise to osteoblasts in the adult, they
contribute to the development of stromal components within
bone marrow before and soon after birth (Mizoguchi et al.,
2014). Therefore, in Osx/ fetal bone marrow, critical stromal
components, including nestin-expressingMSCs (Me´ndez-Ferrer
et al., 2010), CXCL12-abundant reticular cells (Sugiyama et al.,
2006), adipocytes (DiMascio et al., 2007), and even neurons of
the sympathetic nervous system (Katayama et al., 2006), may90, October 23, 2014 ª2014 The Authors 587
be poorly developed, contributing to the defects in HSC cell-
cycle control and engraftment potential that we observed.
In fact, phenotypically identical HSCs (LinCD41Sca1+c-
Kit+CD48CD150+) isolated from the endosteal versus central
marrow regions of adult bone, where there are significant differ-
ences in stromal composition, exhibit different engraftment abil-
ities (Grassinger et al., 2010; Guezguez et al., 2013; Oguro et al.,
2013).
Further studies are clearly needed to define the molecular
mechanisms by which specific niche components regulate the
establishment and maintenance of LT-HSCs during develop-
ment. However, thus far, our data suggest that the vasculature
maintains HSPCs during the development of osteolineage cells,
which supports the HSC-niche crosstalk model. That is, HSCs
are thought to promote the differentiation osteolineage cells
(Jung et al., 2008), which then provide signals needed to induce
quiescence and enable the development and maintenance of
LT-HSCs (Me´ndez-Ferrer et al., 2010).
Our study provides insights into the establishment of the bone
marrow niche during fetal development. Continuing to study this
process in genetically malleable models, in parallel with studies
of the regulation of hematopoiesis in the adult, will provide col-
lective insights needed to optimize cell therapies, as well as
generate and maintain HSCs outside the body, for the treatment
of hematopoietic disorders.
EXPERIMENTAL PROCEDURES
Fetal Bone Marrow Cell Isolation
Animal experiments were approved by the Institutional Animal Care and Use
Committees (IACUC) of Baylor College of Medicine and Yale University.
Osx+/mice (Nakashima et al., 2002) were obtained from Dr. Benoit de Crom-
brugghe, University of Texas MD Anderson Cancer Center. Mouse breeding
pairs (C57BL/6 and C57BL/6Osx+/) weremonitored daily early in themorning
for vaginal plugs; plugged mice were labeled as E0.5. Embryos from E14.5–
E18.5 and postnatal pups were extracted and dissected. Fetal liver and long
bones were collected in cold HBSS+ medium (Hank’s balanced salt solution,
10 mM HEPES, 2% fetal bovine serum [FBS]) and transferred into DMEM+
medium (Dulbecco’s modified Eagle’s medium, 10 mM HEPES, 2% FBS).
Fetal bone marrow and liver tissues were dissected into small pieces in
DMEM+, and single cell suspensions were obtained via gentle passage
through 18G needles and filtration through 70 mm (bone marrow) or 40 mm
(liver) nylon strainers (BD Falcon).
Dextran-FITC Injections
Live embryos were injected with 100 ml Dextran-FITC (Sigma) via the superficial
temporal vein (Kienstra et al., 2007), andafter 15min, embryosweredecapitated
and fixed in 4% paraformaldehyde overnight at 4C. Following PBS washes,
embryoswere transferred to 30%sucrose and then embedded in optimumcut-
ting temperature (OCT) compound (Sakura Finetek USA). a cryostat (Shandon)
wasused toobtain10-mm-thick tissuesections.Confocal imageswerecaptured
using a Zeiss LSM 510 META confocal inverted microscope.
Fetal Bone Histology
Fetal long bones (femurs) were dehydrated and incubated in staining solu-
tion (0.3% alcian blue in 70% ethanol: 0.1% alizarin red in 95% ethanol:
acetic acid: 70% ethanol in 1:1:1:17 ratio) for 3 days at 37C, as described pre-
viously (Inouye, 1976). Images were captured using a Zeiss Axiovert 200M
microscope.
Immunohistochemistry
Tissues frozen in OCT were sectioned as described above. Immunohisto-
chemistry was performed using primary mouse antibodies at 1:100 (rat588 Cell Reports 9, 581–590, October 23, 2014 ª2014 The Authorsanti-mouse c-Kit [eBioscience], rat anti-mouse sca-1 [eBioscience], goat
anti-mouse CD31 [R&D Systems], and rabbit anti-mouse Col1A1 [Millipore]),
incubated overnight at 4C. Sections were incubated for 1 hr at room temper-
ature (RT) with secondary antibodies (Molecular Probes) diluted 1:1,000 and
then mounted in VectaShield with DAPI (Vector Laboratories) for imaging
and analysis. To visualize bone marrow vasculature, cryosections were also
stained by using isolectin B4-FITC staining solution (Sigma-Aldrich) diluted
in PBLec buffer (1 mM CaCl2, 1 mM MgCl2, 0.1 mM MnCl2, 1% Triton X-100
in PBS). Images were captured with a Zeiss AxioVert 200M microscope and
AxioCamMRM camera and AxioVision software (Carl Zeiss).
Fetal Bone Marrow Cell Phenotyping
For KSL analysis, freshly isolated fetal bone marrow cells were suspended in
ice-cold DMEM+ at 107 cells/ml and stained for 15 min on ice with the anti-
c-Kit-PE, anti-Sca-1-FITC, and phycoerythrin (PE)-Cy5-conjugated lineage
marker antibodies (CD4, CD8, B220, TER119, and Gr-1) (eBioscience).
Samples were then washed with 103 volume of HBSS+ and centrifuged at
2,000 rpm for 8 min at 4C. Cell pellets were resuspended in DMEM+with pro-
pidium iodide (PI; 2 mg/ml), and samples were immediately analyzed/sorted by
flow cytometry (BD FACSAria).
For SP analysis, fetal bone marrow cells were suspended at 106 cells/ml in
DMEMwith 2% FBS/10 mMHEPES, then stained with 5 mg/ml Hoechst 33342
(Sigma-Aldrich) for 90 min at 37C, as described previously (Goodell, 2005).
After centrifugation, the cell pellets were resuspended in cold HBSS+
(HBSS/2% FBS/10 mM HEPES) with PI (2 mg/mL). Analysis and collection of
SP cells were performed on a triple-laser MoFlo instrument (Cytomation
Inc.). All phenotyping experiments were repeated at least three times; data
represent mean ± SEM of all data collected.
Methylcellulose Hematopoietic Colony-Forming Assay
For the in vitro progenitor activity assay, 20,000 WBM cells were isolated from
three distinct anatomical regions of the bone (proximal, middle, and distal)
from E15.5 to E18.5 fetal femurs and cultured on MethoCult GFM3434 culture
medium (STEMCELL Technologies) in 35 mm petriplates. For KSL versus non-
KSL HSPC activity studies, 100 KSL cells or 1000 non-KSL cells were sorted
directly into 200 ml of MethoCult GFM3434 culture medium (STEMCELL
Technologies) in 48-well culture plates. Plates were incubated at 37C with
5% CO2 and scored for colony formation at days 7 and 14. Representative
colony images were taken as described above.
Fetal Bone Marrow Transplantation
To evaluate fetal HSC function in vivo, we performed bone marrow transplan-
tations into irradiated (lethal or sublethal) recipients (adult or P0–P3 neonates).
Embryos were obtained from CD45.2 breeders. A total of 1 3 106 WBM cells
were isolated as described above and resuspended in in PBS with 2% FBS.
Recipients received a double dose of 5 Gy irradiation with a 2–4 hr interval
(lethal dose) (XRAD Cs137 irradiator, J.L. Shepherd and Associates). Adult
recipients were injected with donor cells via tail vein. For neonatal injections,
pups were sedated using mild hypothermia and donor-derived CD45.2
(400.000 WBM) were injected in 100 ml PBS with 2% FBS via the superficial
temporal vein. All transplantations were performed with adult WBM helper
cells (200,000 CD45.1 cells). Engraftment levels were tested at 4, 12, and
20 weeks posttransplantation. All transplantation studies were repeated at
least three times; data represent mean ± SEM of all data collected.
Engraftment Analysis
Mice were sedated with Avertin (Sigma Aldrich) via intraperitoneal injection.
Peripheral blood was withdrawn via retro-orbital bleeding and collected into
tubes containing PBS with 2% Dextran T500, EDTA (3 mg/ml), and heparin
(1 U/ml). After 20 min, the top phase was transferred to new tubes and centri-
fuged at 2,000 rpm for 8min at 4C. The pellet was resuspended in PharM Lyse
(Pharmingen) buffer diluted in H20 (1:10) for 5 min at RT for red blood cell lysis.
After centrifugation, the cell pellets were washed in PBS and resuspended and
stained anti-CD45.1 FITC, anti-CD45.2 APC, and lineage markers (PacB-
conjugated anti-CD4, anti-CD8, anti-CD45R, and PE-conjugated anti-Mac1,
anti-Gr1, anti-CD45R, BD Pharmingen) diluted in PBS with 2% FBS (1:100)
and incubated on ice for 15 min. After washing, samples were resuspended
in HBSS+with PI and analyzed with flow cytometry. Data represent themean ±
SEMof triplicate samples collected at each time point in at least three indepen-
dent experiments.
Cell-Cycle Analysis
Fetal bone marrow cells were isolated as above and resuspended in 1 3 107
cell per mL in 10 mg/ml Hoechst and 50 mg/ml verapamil (Sigma-Aldrich). After
30 min, cells were stained with anti-c-Kit-APC-Cy7, anti-Sca-1-APC, and
FITC-conjugated lineage marker antibodies (CD4, CD8, B220, TER119, and
Gr-1) (1:100 final concentration) and Pyronin Y at 1 mg/ml for 10 min at 37C.
Following washing and resuspension, samples were kept on ice and immedi-
ately analyzed via flow cytometry. Data represent the mean ± SEM of triplicate
samples.
Homing Assay
From E17.5 CD45.2 WT or Osx/ fetuses, 400,000 WBM or fetal liver cells
were isolated and injected into CD45.1 wild-type newborn (P0–P2) mice via
the superficial temporal vein. The recipient neonates were euthanized 24 hr
after cellular injections, and their liver and bone marrow cells were collected
immediately. Cells were incubated with anti-CD45.1-FITC and anti-CD45.2-
APC antibodies (BD Pharmingen) diluted in PBS with 2% FBS (1:100) for
15 min on ice. Following washing and resuspension, samples were kept on
ice and immediately analyzed via flow cytometry to determine the ratio of
donor:recipient cells in bone marrow and liver tissues (Figure 4A).
Analysis of Gene Expression
Fetal bone marrow cells were isolated from the long bones of E17.5 Osx/
and wild-type littermates. Total RNA was isolated using RNAeasy (QIAGEN),
and cDNA was synthesized using iScript cDNA synthesis kit (Bio-Rad).
qPCR reactions were performed using the Fast EVAGreen Supermix (Bio-
Rad) and analyzed using the CFX-96 Touch Real Time PCR Detection System
(Bio-Rad). Primers (Table S1) were designed using PrimerBank (Wang et al.,
2012). Data represent the mean ± SEM of triplicate samples from at least three
independent experiments.
Statistical Analysis
Data were evaluated using either the Student’s two-tail t test or two-way
ANOVA; p < 0.05 was considered to be statistically significant.
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